Skip to main content
Fig. 3 | Trials

Fig. 3

From: A pilot randomized controlled trial of 7 versus 14 days of antibiotic treatment for bloodstream infection on non-intensive care versus intensive care wards

Fig. 3

Sample size implications of expanding the BALANCE main RCT to include non-ICU ward patients, as a function of the final percentage of patients enrolled from non-ICU wards and fixing the non-inferiority margin at 4%. The point estimates (solid black line) assume a mortality rate of 17.3% among ICU patients and 12.8% in non-ICU ward patients, with 95% certainty estimates around those estimates (gray shaded area)

Back to article page

Trials

ISSN: 1745-6215